Milestone 3 (Year 2; BIM 6)
Identification of at least one optical probe upon in silico and in vitro preliminary screening.
Upon synthesis and computational studies, additional screening analyses will be conducted to select valid candidates for cell studies.
Milestone 4 (Year 2; BIM 6)
Obtaining efficient optical probes and selective PDT agents upon experiments on HepG2 hepatocarcinoma cells and normal human hepatocytes.